Nuzenio

Ipo With Three

Ipo With Three news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Delicious, K&S I&C to List on KOSDAQ as Three Firms Open IPO Subscriptions - Seoul Economic DailySeoul Economic Daily · Sun, 09 Aug 2026 21:00:05 GMTCXMT's IPO brings demand opportunities to three new chemical materials tracks. - ChemNetChemNet · Thu, 06 Aug 2026 11:48:08 GMTUpdated: Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3 - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 06:56:00 GMT3 Reasons Investors Should Avoid Jersey Mike's Stock After Its IPO - The Motley FoolThe Motley Fool · Wed, 05 Aug 2026 18:07:00 GMTAttovia extends biotech IPO streak with $289M listing for three I&I drugs - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 11:00:00 GMTAttovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 10:58:58 GMTFunding Roundup: Braveheart, Attovia, Vogenx All Announce IPO’s - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 31 Jul 2026 13:42:10 GMTThree's an IPO crowd: biotech trio set to raise $575M in total - FirstWord PharmaFirstWord Pharma · Fri, 31 Jul 2026 00:11:36 GMT

Timeline

Sun, 09 Aug 2026 21:00:05 GMTDelicious, K&S I&C to List on KOSDAQ as Three Firms Open IPO Subscriptions - Seoul Economic Daily
Thu, 06 Aug 2026 11:48:08 GMTCXMT's IPO brings demand opportunities to three new chemical materials tracks. - ChemNet
Thu, 06 Aug 2026 06:56:00 GMTUpdated: Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3 - Endpoints News
Wed, 05 Aug 2026 18:07:00 GMT3 Reasons Investors Should Avoid Jersey Mike's Stock After Its IPO - The Motley Fool
Wed, 05 Aug 2026 11:00:00 GMTAttovia extends biotech IPO streak with $289M listing for three I&I drugs - Endpoints News
Wed, 05 Aug 2026 10:58:58 GMTAttovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ipo With Three.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.